- Research works
- 1 ▲ 100% vs 2013–17
- Citations
- 25 17.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Pharmasum Therapeutics (Norway) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Pharmasum Therapeutics (Norway) publish most on?
By volume in 2022–2025: Down syndrome and intellectual disability research, Alzheimer's disease research and treatments, Renal Diseases and Glomerulopathies and Chronic Kidney Disease and Diabetes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Down syndrome and intellectual disability research Public Health, Environmental and Occupational Health 0 works
- 2 Alzheimer's disease research and treatments Physiology 0 works
- 3 Renal Diseases and Glomerulopathies Nephrology 0 works
- 4 Chronic Kidney Disease and Diabetes Nephrology 0 works
- 5 Renin-Angiotensin System Studies Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pharmasum Therapeutics (Norway)'s research output changed?
Output in 2018–2022 was 100% higher than in 2013–2017.
Other research institutions in Tromsø
- UiT The Arctic University of Norway
- University Hospital of North Norway
- Nofima
- Centre for Arctic Gas Hydrate, Environment and Climate
- Norwegian Polar Institute
- The FRAM Centre
- Akvaplan-niva
- Tromsø research foundation
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.